CG Life

You’ve finalized your pitch. You’ve got the new suit. You’ve lined up 5 solid meetings. You’re ready for the 2025 JPM Healthcare Conference. The CG Life team of David Ormesher Erik Clausen Karen Sharma Todd Kuna and Kelly Biele is available to meet to talk through your challenges of bringing precision medicines for patients with rare and difficult-to treat diseases to market. Connect with our team and let us help you keep that momentum going. Drop us a line at jpm@cglife.com to get started   #JPM2025 #rarediseaseagency #lifesciencemarketing #lifesciencecommunications

As you make your 2025 preparations, we have you covered to meet your goals. Kick off the 2025 JP Morgan Healthcare Conference on the right foot and join CG Life’s first-ever Sweat Equity 5K in the heart of downtown San Francisco! Join us and our partners STAT MC Services AG and Gilmartin Group LLC on January 13 for a knee-friendly fun run! Register today! https://lnkd.in/gsmkXP9N #JPM2025 #lifesciencecommunications #lifesciences

Proteins are foundational building blocks of life with a wide range of structures and functions. Until recently, understanding protein shapes - a critical component of understanding and treating diseases - often required months or even years. Thanks to AlphaFold, a concrete example of AI revolutionizing science, protein structure prediction models are no longer the dream, but reality. While the full power of this advance is still being revealed, a key area of opportunity is the study and treatment of rare diseases. Our own Josh Frost, PhD gives us an in-depth look at the potential and promise of this Nobel Prize winning advance. https://bit.ly/4hUGKQL #AI #lifescience #lifescienceresearch

We're looking forward to connecting with the Philadelphia life science community this Wednesday. It's not too late to secure your spot! #LifeSciencesPHL #lifesciencecommunications #healthcarecommunications

Are you ready to run 👟? Join CG Life for our inaugural Sweat Equity 5K at the 2025 JP Morgan Healthcare Conference. Start your week on a high note with a knee-friendly run through downtown San Francisco, reconnecting with familiar faces and meeting new ones along the way. Register today and join us for this exciting kickoff event!  Thanks to our friends MC Services AG STAT and Gilmartin Group LLC for co-sponsoring this event! https://lnkd.in/gsmkXP9N #JPM2025 #lifesciences #lifesciencecommunications

CG Life is excited to co-sponsor the Philadelphia's Irish American Business Chamber & Network (IABCN) 2024 John Brennan Life Sciences Summit on November 20!. We're looking forward to hearing insights about the future of Philadelphia's vibrant life sciences ecosystem. Make sure to register now to hear this exciting panel. https://lnkd.in/esqYi3iX

We’re excited to announce that Allison Davis has joined CG Life as Chief Client Officer! In this newly created role, Allison will leverage her over 20 years of client leadership experience in the life science and healthcare industries, to lead the CG Life account team in fostering strategic and lasting client relationships and delivering exceptional client service. https://lnkd.in/gc-shQeP

ICYMI, November 10 was World Science Day! As science communicators, we help all kinds of audiences—from researchers to clinicians, patients, and the general public—understand complex scientific concepts. So we're launching a new occasional series focusing our science communication on different types of drugs, aka drug modalities. Welcome to Modality Mondays! You may have heard these mentioned, but perhaps want to know more about how some of the lesser-known approaches work to treat various diseases. These newer drug modalities build on the traditional small molecules and biologics, offering unique mechanisms of action. Their existence opens up new frontiers in drug development, particularly for the treatment of complex and rare diseases, cancer, or genetic disorders where traditional small molecules and biologics may not be sufficient. Up first - antisense oligonucleotides (ASOs)! This nifty modality is made of short, synthetic strands of nucleic acids designed to bind to specific RNA sequences. By binding to mRNA, the ASOs can modulate gene expression, typically by blocking protein translation or altering splicing patterns. We love to explain science! #lifescience #lifesciencecommunications #precisionmedicine

From autonomous cars to autologous cell therapies, there was plenty of excitement at Cell & Gene: Meeting on the Mesa. In this blog, we recap some of the hottest conference trends, including renewed focus on patient access and rare diseases. https://lnkd.in/g87SErD7 #cellandgenetherapy #CGMesa24 #lifesciencemarketing #lifesciencecommunications

The highly competitive nature of the biopharma industry makes differentiation absolutely critical. Telling your origin story, cultivating transparency, and ensuring patient engagement are all ingredients for success. Leveraging the right communication strategies can help companies establish and grow differentiation to build value while developing life-changing therapies. Our own Karen Sharma offers key insights on the role of communications on securing long-term growth and success in this fast-paced industry. https://lnkd.in/g8v3tVUc #lifesciencecommunications #healthcarecommunications #biopharma